Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
The SLC22A1 influx transporter is expressed on the basolateral membrane of hepatocytes and is involved in the excretion of numerous cations. Inhibition of SLC22A1 by several antiretrovirals, such as the protease inhibitor darunavir, has not previously been determined. In order to better understand a...
Main Authors: | Darren eMoss, Neill eLiptrott, Marco eSiccardi, Andrew eOwen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00078/full |
Similar Items
-
Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
by: Fizalah Kawoosa, et al.
Published: (2022-05-01) -
Effect of Metformin on Glycemic Control Regarding Carriers of the SLC22A1/OCT1 (rs628031) Polymorphism and Its Interactions with Dietary Micronutrients in Type 2 Diabetes
by: Zepeda-Carrillo EA, et al.
Published: (2022-06-01) -
Functional and Pharmacological Comparison of Human, Mouse, and Rat Organic Cation Transporter 1 toward Drug and Pesticide Interaction
by: Saskia Floerl, et al.
Published: (2020-09-01) -
OCT1 Polyspecificity—Friend or Foe?
by: Marleen J. Meyer, et al.
Published: (2021-06-01) -
PHARMACOGENETICS OF ORGANIC CATION TRANSPORTERS
by: V. A. Evteev, et al.
Published: (2018-06-01)